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Abstract 
 
Alcohol has been consumed by most societies over the last 7000 years. Abraham Lincoln 
said “It has long been recognized that the problems with alcohol relate not to the use of a 
bad thing, but to the abuse of a good thing.” Light to moderate alcohol consumption 
reduces the incidence of coronary heart disease (CHD), ischemic stroke, peripheral 
arterial disease, CHD mortality, and all-cause mortality, especially in the western 
populations. However, heavy alcohol consumption is detrimental causing 
cardiomyopathy, cardiac arrhythmias, hepatic cirrhosis, pancreatitis, and hemorrhagic 
stroke. In this article, we review the effects of alcohol on CHD, individual cardiovascular 
risk factors, cardiomyopathy, and cardiac arrhythmias, including the most recent 
evidence of the effects of alcohol on CHD.  
 
Alcohol and Global Burden of Disease 
 
An estimated 3·8% of all global deaths are attributable to the detrimental effects of 
alcohol consumption.[1] Disease burden and disability are closely related to the volume 
of alcohol consumption.[1] Alcohol dependence is a major health and social issue 
affecting 4 to 5% of the United States population at any given time,[2] with a lifetime 
prevalence of 12.5%.[3] In the United States, approximately 30% of those who drink 
alcohol do so excessively. Excessive drinking is the third leading preventable cause of 
death, accounting for 79,000 deaths annually, and resulting in approximately 2.4 million 
years of potential life lost.[4, 5] Heavy drinkers (> 6 drinks) had a doubled mortality rate, 
and consumption of 3 to 5 drinks was associated with a 50% higher mortality rate.[6]  
However, moderate alcohol consumption is protective against CHD,[7] with higher 
cardiovascular event rates occurring among abstainers and heavy drinkers. There is a 
plethora of epidemiological evidence, demonstrating a J- or U-shaped association 
between alcohol consumption and all-cause mortality (Figure 1),[8] as well as 
cardiovascular morbidity and mortality (Figure 2).[9] However, this hypothesis was 
challenged by a meta-analysis that showed a lack of benefit of alcohol in preventing 
CHD.[10] In addition, ethnicity, gender, type of alcoholic beverage, and pattern of 
alcohol intake, may also influence the relation between alcohol and CHD. 
 
Epidemiological Studies Showing a Favorable Effect of Alcohol on the 
Heart 
Ethanol consumption showed a strong U-shaped relationship with CHD mortality for 
male nonsmokers, and heavy smokers, irrespective of beverage type, and for female 
smokers, after a 24-year follow-up. In nonsmokers, beer and wine were associated with 
greater reductions in CHD mortality than spirits.[11] Light and moderate alcohol 
consumption were inversely associated with cardiovascular mortality over a 25 year 
period, even when compared with lifetime abstainers.[12] 
 
In a pooled analysis of 8 prospective studies from North America and Europe, including 
192,067 women and 74,919 men free of cardiovascular diseases and diabetes, there was 
an inverse association between alcohol and risk of CHD in all age groups.[13] In the 
Health Professionals Follow-up Study, moderate alcohol intake was associated with 
lower risk for myocardial infarction (MI) in men free of major illness, during 16 years of 
follow-up of 8867 physicians.[14] A prospective cohort study of 64,597 Chinese men 
aged > 40 years, who were free of clinical CHD, showed alcohol consumption was 
associated with a lower risk of MI and CHD after 494,084 person-years follow-up.[15] 
Maintaining alcohol consumption below 46g/day in men and 23g/day in women appears 
to minimize the risks of mortality in a Japanese population, based on a pooled analysis of 
six ongoing large-scale cohort studies (n = 309,082). There was a J- or U-shaped 
association for the risk of total and major causes of mortality in men, and the risk of total 
and heart disease mortality in women.[16] A J-shaped relation between alcohol 
consumption and incident cardiovascular disease (CVD), and total and CVD deaths was 
found during a mean follow up of 12.2 years in 26,399 women.[17] Compared with 
abstainers, alcohol intake of 5 to 14.9 g/d was associated with 26%, 35%, and 51% lower 
risk of CVD events, total death, and CVD death, respectively, in a multivariable 
model.[17] In a Japanese study of 34,776 men and 48,906 women aged 40 to 79 years, 
followed-up for a median duration of 14.2 years, heavy alcohol consumption was 
associated with increased CVD mortality in men, and CHD in women, whereas light-to-
moderate drinking was associated with reduced CVD mortality in both sexes.[18] 
 
In the Nurses’ Health study of 87,526 female nurses aged 34 to 59 years, moderate 
alcohol consumption decreased the risks of CHD during 334,382 person-years of follow-
up, compared with nondrinkers.[7] In the Women's Health Initiative (WHI) comprising 
10,576 black and 105,610 white postmenopausal women free of cardiovascular disease, 
moderate drinking was associated with a lower risk of total mortality among Caucasian 
women during a mean follow-up of 8 years, regardless of hypertensive status, but only in 
hypertensive African-American women.[19] In the Swedish Women's Lifestyle and 
Health Study of 47,921 women aged 30-49 years, a significant inverse association was 
found between light to moderate drinking and total mortality. This was predominantly 
driven by reduction in cardiovascular mortality, during 713,295 person-years follow-
up.[20] In the Women's Health Initiative Observational Study, during the 22,546 person-
years of follow-up, both frequency and quantity of alcohol intake were inversely 
associated with the risk of developing CHD, irrespective of the beverage type.[21] 
Moderate alcohol consumption in postmenopausal women may have a benefit on CHD, 
irrespective of their diabetic status.[21] In the Nurses' Health Study, moderate alcohol 
consumption was associated with reduced CHD risk in women with diabetes, during 
39,092 person-years of follow-up.[22] Moderate alcohol consumption was protective 
against coronary atherosclerosis progression demonstrated by quantitative coronary 
angiography in the Stockholm Female Coronary Risk Angiographic Study.[23]  
 
Moderate alcohol consumption also reduces mortality in patients with documented CVD. 
Light to moderate alcohol consumption (5 to 25 g/day) was associated with a lower 
incidence of CVD events and all-cause mortality in a recent meta-analysis of 8 
prospective studies including 16,351 subjects with history of CVD. J-shaped pooled 
curves were observed with both CVD and all-cause mortality.[9] In patients with 
clinically manifest vascular disease or diabetes (n = 5447) from the Second 
Manifestations of Arterial Disease (SMART) study, moderate alcohol consumption (1–2 
drinks/day) was not only associated with a reduced risk of vascular and all-cause death, 
but also with reduced risks of non-fatal events from CHD, stroke and amputations.[24] In 
the Prospective Epidemiological Study of Myocardial Infarction (PRIME), in Northern 
Ireland and France, regular and moderate alcohol intake was associated with a low risk of 
CHD, whereas the binge drinking pattern conferred a higher risk.[25] Only wine drinking 
was associated with a lower risk of hard coronary events.[25] Moderate alcohol intake 
was inversely associated with CHD in hypertensive men in the Physicians' Health Study, 
and Health Professionals Follow-Up Study, after 26- and 16-year follow-ups, 
respectively.[26, 27] 
 
Moderate alcohol consumption in the year prior to acute MI was associated with reduced 
total and CV mortality following infarction, irrespective of gender and beverage type,[28] 
and a significant reduction in cardiovascular complications in survivors of acute MI.[29] 
In the Stockholm Heart Epidemiology Program (SHEEP) study, moderate alcohol 
drinking was beneficial following acute MI, after a median follow up of 8 years.[30] In 
the Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan 
(OPTIMAAL) trial, there was a strong positive association between moderate alcohol use 
and survival in patients with heart failure and/or evidence of left ventricular dysfunction 
following MI.[31] Persistent moderate alcohol drinking following an acute MI was 
associated with a trend toward less angina, fewer re-hospitalizations, lower 3-year 
mortality, and better disease-specific quality of life, and mental health than quitters.[32] 
In the Post-CABG trial, inverse trends were observed between moderate drinking and 
morbidity as well as graft disease progression.[33] 
 
Epidemiological Studies Showing Neutral Results of Alcohol on the 
Heart 
 While a great many studies have shown favorable effects on CHD and all-cause mortality 
with light to moderate alcohol intake (Table 1), some studies have shown a neutral effect, 
and heavy alcohol consumption was shown to be detrimental. In the Framingham Study, 
cumulative incidence of alcohol use disorders did not show a decrease despite a decrease 
in average alcohol intake and more wine consumption after more than 50 years of follow-
up.[34] Contrary to the cardioprotective effect of moderate regular alcohol consumption, 
heavy, episodic drinking was related to higher risk of CHD,[35] and indeed in a 
prospective study of patients with MI, although moderate alcohol intake was associated 
with lower mortality, binge drinking, even among light drinkers, was associated with 2-
fold higher mortality.[36] A meta-analysis of 14 studies showed the cardioprotective 
effect of moderate alcohol consumption disappears when, on average, light to moderate 
drinking was mixed with irregular heavy drinking (>60 g of pure alcohol or > or =5 
drinks per occasion at least monthly).[37] Former drinkers compared to long-term 
abstainers had significantly increased risk for CHD mortality, in a recent meta-
analysis.[38] In a meta-analysis of six studies, a J-shaped curve, with nadir of 
approximately 28 grams of alcohol (2 drinks) per week, was observed including drinkers 
who consumed alcohol for 2 days a week or less. Conversely, in people who consumed 
alcohol for more than 2 days a week, a significant protective effect was seen even when 
drinking high amounts of alcohol.[39] In a meta-analysis of 28 cohort studies, there was a 
20% relative risk reduction in CHD for up to 20 g/day of alcohol consumption, and 
evidence of a protective effect up to 72 g/day, but increased risk above > 89 g/day.[40] 
 
The beneficial effects of light to moderate alcohol consumption on CHD could not be 
replicated in some studies, especially in studies of certain ethnic populations. Table 2 lists 
studies showing no favorable effects of light to moderate alcohol consumption on 
cardiovascular or all-cause mortality. In the NHANES Epidemiologic Follow-Up Study 
(NHEFS), no J-shaped beneficial relationship was found between alcohol consumption 
and mortality in African Americans. Conversely, mortality increased with increasing 
consumption of more than one drink a day in both genders.[41] Risk for all-cause 
mortality was similar for non-drinkers and men drinking up to 14 units per week (1 unit 
was equivalent to one measure of spirits, half a pint of beer, or one sixth bottle of wine) 
in Scottish men followed-up for 21 years, with an unfavorable outcome for drinking over 
22 units a week.[42] In Asian-Indian men, no protective association was found between 
alcohol intake and prevalence of CHD. In fact, alcohol intake was associated with a 
higher odds ratio for CHD risk.[43, 44] Moderate-to-heavy alcohol consumption not only 
showed lack of benefit on CHD mortality in older Chinese men,[45] but also increased 
the risk of angiographically proven CAD.[46] In the Lipid Research Clinics Prevalence 
and Follow-up Studies, no difference in mortality rates were found between drinkers and 
non-drinkers in Russia.[47] In a cohort of males of high socioeconomic status, moderate 
alcohol consumption had no net benefit compared with abstinence, and > 3 drinks per day 
was associated with worse quality of life, and adversely affected mortality after a 29-year 
follow-up.[48]  
 
In a population based prospective study of 7169 men aged 45-64 years followed for a 
mean of 12.8 years, compared to occasional drinking, regular light alcohol consumption 
(1-14 units per week) in men with established CHD was not associated with any 
significant benefit, or all cause mortality. Higher levels of intake (>/= 3 drinks per day) 
were associated with increased mortality in men with previous MI.[49] In the Multi-
Ethnic Study of Atherosclerosis (MESA) study, heavy consumption of hard liquor was 
associated with greater coronary artery calcium accumulation and there was no evidence 
of a protective or J-shaped association of alcohol and coronary artery calcium over a 2- to 
4-y period.[50] Alcohol consumption was directly associated with carotid intima-media 
thickness in young healthy adults, independent of cardiovascular risk factors, suggesting 
a pro-atherogenic effect.[51] 
 
Lack of replication of the well documented protective effect of moderate alcohol use in 
some studies could suggest that the protective effect of alcohol on CHD does not extend 
to all populations or that the confounding factors may not have been completely 
accounted for. Moreover, self reporting of alcohol consumption may have been less 
accurate rather than actual consumption. Other factors that may have contributed to the 
neutral effects of alcohol consumption include differences in the ethanol content, serving 
size, pattern of consumption, and phenotypic differences in the metabolism of alcohol. A 
meta-analysis of 54 all-cause mortality studies and 35 CHD mortality studies,[10] 
highlighted systemic,[52] and misclassification errors from the epidemiological studies, 
that demonstrated a J- or U-shaped benefit with alcohol consumption. However, this 
study was limited by the exclusion of some major studies which showed positive effects 
of alcohol on CHD. Another recent large systematic review and meta-analysis addressed 
this issue, and inclusion of former drinkers did not seem to bias the beneficial association 
of alcohol consumption with cardiovascular disease.[53] 
 
Alcohol Consumption and Vascular Disease 
 
Light to moderate alcohol consumption decreases risk of ischemic stroke, but heavy 
alcohol consumption may increase the risk of total stroke.[7, 54, 55] Moderate alcohol 
consumption also decreases risk of peripheral arterial disease.[56-59]  
 
Alcohol and Cardiovascular Risk Factors 
 
Moderate alcohol consumption has been associated with lower CHD risk in numerous, 
but not all, epidemiological studies. Alcohol reduces many but not all of the risk factors 
for CHD. The 2003 Behavioral Risk Factor Surveillance System data showed, while 27 
of the 30 CHD-associated factors were significantly more prevalent in nondrinkers, 
compared to moderate drinkers, after adjusting for age and gender, few (if any) of these 
differences were likely due to alcohol consumption itself.[60] There was a J- or U-shaped 
relationship between alcohol intake and the prevalence of multiple cardiovascular risk 
factors, amongst non-smokers and smokers, in 27,005 middle aged Japanese men.[61] In 
the Italian Longitudinal Study on Aging (ILSA), moderate alcohol consumption at older 
age was associated with healthier hematological values of fibrinogen, HDL cholesterol 
(HDL-C), apo A-I lipoprotein and insulin. But it was also associated with a worse 
hematological picture of total cholesterol, LDL cholesterol (LDL-C) levels, and systolic 
blood pressure.[62] 
 
Alcohol and Lipids 
CHD risk reduction in light to moderate alcohol drinkers is generally attributed to a 
beneficial effect on HDL-C levels. However, this hypothesis was disputed recently in 
a large, population based Norwegian cohort (CONOR) study with extensive control 
for confounding factors.[63] Alcohol intake increases HDL-C in a dose-dependent 
fashion up to 18%, associated with and possibly caused by an increase in the 
transportation rates of HDL apolipoproteins apoA-I and A-II.[64] HDL-C and apoA-I 
levels were significantly elevated in the Atherosclerosis Risk in Communities (ARIC) 
study, irrespective of the quantity or type of beverage consumed.[65] In a meta-analysis 
of 42 studies, 30 g of ethanol a day increased concentrations of HDL-C by approximately 
4 mg/dl, and apoA-I by 8.82 mg/dl, with an estimated risk reduction of 24.7% in 
CHD.[66] In a recent systematic review and meta-analysis of 44 studies, alcohol 
significantly increased levels of HDL-C, apoA1, and adiponectin. Alcohol showed a 
dose-response relation with HDL-C, decreased fibrinogen levels, and did not affect 
triglyceride levels.[67] 
 
Incremental alcohol intake was associated with significantly elevated levels of HDL-C, 
phospholipid enrichment of HDL, and a shift from HDL 3 subfraction to HDL 2, all of 
which, may augment the antiatherogenic effect of HDL-C.[68] Cholesterol efflux from 
macrophages to HDL (2) particles was significantly increased by heavy alcohol 
consumption, with associated decrease in cholesteryl ester transfer protein (CETP) 
activity, and increased phospholipid transfer protein (PLTP) activity.[69] Moderate 
alcohol consumption increased cholesterol efflux, possibly mediated by ATP-binding 
cassette transporter (ABCA1) in healthy men,[70] and in postmenopausal women.[71] 
 Serum non-HDL cholesterol is a strong predictor of cardiovascular diseases. Even light 
drinking significantly lowered serum non-HDL cholesterol in healthy adults, with the 
effect more pronounced in women.[72] In the Cardiovascular Health Study, alcohol 
intake was associated with less total LDL particles, lower levels of small LDL, HDL, and 
very-low-density lipoprotein particles, and higher levels of large LDL and medium- and 
large-sized HDL particles, as measured by nuclear magnetic resonance (NMR) 
spectroscopy.[73] 
 
Genetic polymorphisms and their interaction with alcohol consumption have been 
implicated in modulating serum lipid levels. Genetic variation in alcohol dehydrogenase 
1C (ADH1C) and ADH3 have higher HDL levels and a substantially decreased risk of 
CHD in moderate drinkers,[74, 75] but this finding could not be replicated in the British 
Women's Heart and Health Study and Caerphilly cohorts.[76] Apolipoprotein E (APOE) 
polymorphism and its interaction with alcohol, altered LDL-C levels in the Framingham 
Offspring Study,[77] and in the Spanish EPIC cohort study.[78] Data from the Cohorte 
Lausannoise (CoLaus) study suggests that the effect of alcohol consumption on HDL-C 
levels may not be mediated by polymorphisms in APOA5, CETP, LIPC or LPL 
genes.[79] 
 
 
 
Alcohol and Diabetes Mellitus 
 
Light to moderate alcohol consumption was inversely associated with type 2 diabetes in 
4,655 elderly people in the Cardiovascular Health Study,[80] 2,879 healthy adults in the 
Framingham Offspring Study,[81] and 20,951 physicians in the Physicians' Health Study 
after a median follow up of 12.1 years.[82] In a systematic review and meta-analysis 
comprising of 20 cohort studies, moderate alcohol consumption appeared protective for 
type 2 diabetes with a U-shaped relationship in both sexes.[83] Moderate alcohol 
consumption improved insulin sensitivity in relatively insulin-resistant middle-aged men, 
an effect that may be mediated through alcohol-induced increases in adiponectin.[84] In a 
nested case-control study, the inverse association between alcohol consumption and risk 
of type 2 diabetes was not explained by circulating biomarkers of inflammation, 
endothelial dysfunction, and fasting insulin, but adiponectin appeared to be a 
mediator.[85] 
 
Light to moderate alcohol consumption was associated with lower risk of CHD in men 
with type 2 diabetes in the Health Professionals' Follow-up study (HPFS),[86] as well as 
in the Physicians' Health Study,[87] and decreased risk of death due to CHD.[88] In a 
meta-analysis of six cohort studies, moderate alcohol consumption was associated with a 
lower risk of total mortality and any alcohol consumption was associated with lower risk 
of CHD in type 2 diabetic populations.[89] 
 
Alcohol consumption was also associated with a lower prevalence of metabolic syndrome 
in the NHLBI Family Heart Study, irrespective of the type of beverage consumed,[90] 
and in European population cohorts.[56, 91, 92] In a meta-analysis of 7 studies, alcohol 
consumption of less than 40 g/day in men and 20 g/day in women significantly reduced 
the prevalence of metabolic syndrome.[93] 
Alcohol and Hypertension 
 
Existing evidence is conflicting regarding the relation between alcohol consumption and 
systemic hypertension. 
 
In a systematic review and meta-analysis comprising 12 cohort studies from the United 
States, Japan and Korea, the risk for hypertension increased linearly with alcohol 
consumption. Among women, a significant protective effect was reported for 
consumption at or below about 5 g per day. Among men, Asian populations had higher 
risks than non-Asian populations of hypertension associated with alcohol intake.[94] In 
the Coronary Artery Risk Development in Young Adults Study, 20-year follow up 
showed no association between alcohol consumption and incident hypertension, except 
among European-American women in whom any current alcohol consumption was 
associated with lower risk of incident hypertension.[95] In the ARIC study participants, 
the consumption of alcohol in amounts > 210 g per week was an independent risk factor 
for hypertension in North America, after 6 years of follow-up. Light to moderate alcohol 
consumption also appeared to be associated with a higher risk of hypertension in black 
men.[96] 
 
Light-to-moderate alcohol consumption decreased hypertension risk in women and 
increased risk in men, after prospective follow-ups of 10.9 and 21.8 years, in the 
Women's Health Study and Physicians' Health Study, respectively. The threshold above 
which alcohol became deleterious for hypertension risk emerged at > 4 drinks per day in 
women versus a moderate level of > 1 drink per day in men.[97] In Spanish men and 
women, consumption of beer or spirits, but not wine, was associated with a higher risk of 
developing hypertension, during a median follow-up of 4.2 years, irrespective of the 
pattern of consumption.[98] 
 
The mechanisms that lead to alcohol-induced hypertension have not been well defined. 
In a study of healthy volunteers, higher blood pressure in drinkers, was not explained by 
increased activity of the sympatho-adrenal and renal-pressor mechanisms.[99] Light-to-
moderate alcohol intake appeared to have a possible vasculoprotective effect, as 
measured by pulse wave velocity in subjects with optimal or normal blood pressure, 
while heavy drinking caused a detrimental effect on the vasculature.[100] Increased 
aortic pulse wave velocity was closely associated with alcohol consumption in middle-
aged Japanese men.[101] 
 
Polymorphisms of alcohol-metabolizing enzymes (alcohol dehydrogenase (ADH) 2 and 
aldehyde dehydrogenase (ALDH) 2 may influence alcohol metabolism. One such 
polymorphism, ADH2(1)/2(1) genotype, was associated with lower levels of systolic 
blood pressure.[102] Genotypic variations in Catechol- O-methyltransferase (COMT) 
mRNA and the consequent genetically determined inactivation of catecholamines, may 
influence alcohol-induced blood pressure elevation.[103] 
 
 
Alcohol and Coagulation 
 
Epidemiological studies indicate that consumption of alcohol at the average level of 
intake in France (20-30 g per day) reduced risk of CHD by at least 40%, despite a high 
intake of saturated fat. This “French Paradox,” may be attributable to regular wine 
consumption. Alcohol is believed to protect from CHD by preventing atherosclerosis 
through action on HDL-C, but serum concentrations were no higher in France than in 
other countries. The effect of wine in lowering the platelet reactivity, as seen in France 
compared to Scotland, may be one explanation for this protection.[104] 
 
In the Framingham Offspring Study, light-to-moderate alcohol consumption was 
associated with lower levels of coagulatory factors (fibrinogen, plasma viscosity, von 
Willebrand factor, and factor VII), but higher intake was associated with impaired 
fibrinolytic potential, reflected by higher levels of plasminogen activator inhibitor 
antigen-1 and tissue plasminogen activator antigen. These findings are consistent with the 
hypothesis that a balance between hemostatic and fibrinolytic activity may contribute to 
the complex relation of alcohol use with coronary heart disease.[105, 106] 
 
A dose-dependent effect of alcohol on decreased platelet aggregation was also seen in the 
Caerphilly Prospective Heart Disease Study.[107] In a meta-analysis of 42 studies, 30 g 
of daily alcohol consumption modestly increased concentrations of several haemostatic 
factors including fibrinogen.[66] Wine drinkers had lower levels of plasminogen 
activator inhibitor (PAI) antigen-1, and ADP-mediated platelet activation and aggregation 
compared to others.[66] 
 
Moderate alcohol intake was positively associated with plasma level of endogenous t-PA, 
independent of HDL-C in the Physicians' Health Study.[108] In the NHLBI Family Heart 
Study, alcohol consumption > 15g/d was associated with increased PAI-1.[109] These 
findings support the hypothesis that changes in fibrinolytic potential may be an important 
mechanism whereby moderate alcohol consumption decreases risk of heart disease. 
Moderate alcohol consumption also improved endothelial function as evidenced by better 
flow-mediated dilation (FMD) in the Northern Manhattan Study (NOMAS).[110] 
 
Alcohol and Inflammation 
 
In view of the robust association between markers of inflammation, especially C-reactive 
protein (CRP), and risk of CHD, an anti-inflammatory action of alcohol could contribute 
to the link between moderate consumption and lower cardiovascular mortality. 
Multiple studies have demonstrated the beneficial effects of moderate alcohol 
consumption on various inflammatory markers with significantly decreased levels of 
plasma CRP, fibrinogen, interleukin-6 (IL-6), interleukin-1alpha, as well as plasma 
viscosity, WBC count, factor VIIIc, and monocyte and endothelial adhesion 
molecules.[111-115] Men who consumed 1-2 drinks/day had 26% lower CRP, and 36% 
lower IL-6 levels, with a stronger association in women.[116] Lower CRP concentrations 
were also observed in the Pravastatin Inflammation/CRP Evaluation Study, independent 
of alcohol-related effects on lipids.[117] These results suggest an additional biological 
explanation to the epidemiological link between moderate alcohol consumption and 
decreased cardiovascular events. 
 
Alcohol Preconditioning 
Epidemiological data suggest that those who are regularly consuming alcohol prior to an 
acute MI are more likely to survive, suggesting a preconditioning effect of alcohol.[28, 
118] Ischemic preconditioning (IPC) is the most potent form of endogenous myocardial 
protection against irreversible ischemia-reperfusion injury. In an animal models, long-
term alcohol consumption reduced myocardial ischemia-reperfusion injury possibly 
through repeated myocyte adenosine receptor activation,[119] and sustained translocation 
of epsilon protein kinase C (εPKC).[120] In situ studies in rabbit showed, ethanol 
exposure followed by washout or sufficient time to metabolize the alcohol prior to 
ischemia, induces preconditioning-like myocardial protection.[121] Protection afforded 
against ischemia and reperfusion injury (I/R) proceeds through an ischemic 
preconditioning-like mechanism involving the activation of εPKC that is dependent on 
the time and duration of ethanol treatment.[122, 123] 
 
Of note, moderate dose of ethanol when taken acutely, abolished ischemic 
preconditioning (IPC) occurring during sequential episodes of myocardial ischemia, and 
is associated with worsening ischemia in a randomized prospective study in 
humans.[124] 
 
Wine versus other Alcoholic Beverages 
Some but not all, epidemiological studies suggest that wine confers greater protection 
against CHD than beer or distilled spirits, by virtue of its polyphenol content.[125] In a 
systematic review and meta-analysis, small doses (1-4 drinks/day) of wine, beer, and 
spirits were equally beneficial in reducing CHD.[126] Another systematic review that 
included ecological, case-control, and prospective cohort studies, also showed that all 
types of alcoholic drinks were linked with lower risk of CHD.[127] However, in a meta-
analysis, relative risk of vascular disease associated with wine intake was 0.68 (95% 
confidence interval, 0.59 to 0.77) in 209 418 persons compared to non-drinkers, with a 
strong J-shaped relationship between different amounts of wine intake and vascular risk. 
A similar but smaller association was also apparent with beer consumption, but no 
meaningful relationship could be found between different amounts of beer intake and 
vascular risk.[128] Potential protective mechanisms beyond the effects of ethanol 
include, greater anti-oxidant effects,[129-131] decreased erythrocyte superoxide 
dismutase activity,[132] and in vitro studies showing reduced vascular smooth muscle 
cells proliferation,[133] vasorelaxation of human coronary arteries,[134] inhibition of 
endothelin-1 synthesis,[135] and down-regulation of tissue factor (TF) gene 
transcription.[136] 
 
Alcohol and Heart Failure 
 
Moderate alcohol consumption was associated with a lower risk of incident heart failure 
among older adults and in the Physicians’ Health Study, independent of a number of 
confounding factors. Further, it did not appear to be mediated by a reduction in MI risk, 
after an extended follow-up of 18 years.[137-139] Light to moderate drinking was 
associated with a lower risk of HF in hypertensive male physicians.[140] In the 
Framingham Heart Study, during 26,035 person-years of follow-up in men, and 35,563 
person-years of follow-up in women, alcohol consumption was not associated with 
increased risk for heart failure, even among heavy drinkers (> 15 drinks/wk in men and > 
8 drinks/wk in women). To the contrary, moderate alcohol consumption protected against 
heart failure.[141] In a meta-analysis of 6 studies, infrequent and light-to-moderate 
drinking was associated with a 10% to 20% lower risk of heart failure.[142] Heavy 
alcohol drinking was associated with increased risk of non-ischemic cardiomyopathy, and 
the apparent protection of alcohol against ischemic cardiomyopathy, supported its 
protective effect against CHD.[143] 
Alcohol is toxic to striated muscle in a dose-dependent manner, and in patients with 
alcoholic cardiomyopathy, total lifetime dose of ethanol correlated inversely with the 
ejection fraction and directly with the left ventricular mass.[144] In the Framingham 
Offspring Study, alcohol intake was positively and independently associated with left 
ventricular mass in men but not in women.[145] Subtle signs of cardiac abnormalities 
such as left ventricular dilation with preserved ejection fraction and impaired left 
ventricular relaxation may precede severe cardiac dysfunction in chronic asymptomatic 
alcoholics.[146] 
Changes in myocardial contractility due to chronic alcohol exposure do not result from 
altered Ca
2+
 handling but from changes at the level of the myofilament that do not 
involve myosin heavy chain isoform shifts.[147] Transgenic overexpression of insulin-
like growth factor 1 attenuated the deleterious effects caused by chronic alcohol intake 
such as interstitial fibrosis, reduced mitochondrial number, compromised cardiac 
contractile function and intracellular Ca(2+) handling, decreased superoxide dismutase 
(SOD) 1 expression, elevated superoxide production, and overt apoptosis, with the 
exception of cardiac hypertrophy.[148] 
Abstinence is the most critical step in halting further deterioration of cardiac contractility 
in alcoholics. In a 4-year prospective cohort study in Spain, left ventricular ejection 
fraction improved in both abstinent patients and those who controlled their drinking up to 
60 grams of ethanol per day.[149] 
 
Like the relationship between alcohol and CHD, the relationship between alcohol and 
CHF is complex. While light to moderate alcohol intake may be protective, heavy 
consumption increases heart failure risk. 
 
Alcohol and Atrial Fibrillation 
 
Moderate alcohol consumption was not significantly associated with a risk of atrial 
fibrillation,[150, 151] but the risk significantly increased when alcohol consumption was 
> 36 g/day during a follow up of > 50 years in the Framingham Study.[150] Heavy 
alcohol consumption was associated with atrial fibrillation in 5% of cases in the 
Copenhagen City Heart Study.[152] In a recent meta-analysis of 14 studies, a linear 
relationship was found between atrial fibrillation risk and alcohol consumption, 
suggesting abstinence from alcohol is most favorable in terms of atrial fibrillation risk 
reduction.[153] 
Conclusion 
 
Current guidelines recommend limiting alcohol intake to one drink per day for 
women, and two drinks per day for men.[154] Existing epidemiological data clearly 
demonstrates many favorable biological effects (Figure 3) of light to moderate 
alcohol consumption on the cardiovascular system. These include cardioprotective, 
anti-inflammatory, anti-oxidant, and hemorheological effects, as well as modulation 
of cardiovascular risk factors. A large body of epidemiological data supports the 
relationship between light to moderate alcohol consumption and a reduction in 
cardiovascular and all-cause mortality; predominantly seen in western populations. 
However, a small number of studies did not demonstrate a benefit of light to 
moderate alcohol consumption, especially in certain ethnic populations. This may 
partly be explained by genetic and metabolic factors, but questions remain 
regarding self-reported data collection in some studies and other confounding 
factors that may not have been accounted for. Further robust studies are needed in 
certain ethnic populations where these benefits could not be replicated. 
 
Cardiovascular benefits of low to moderate alcohol consumption give way to 
cardiovascular complications with heavy or binge drinking. These can include 
cardiomyopathy and heart failure, hypertension, arrhythmias, and stroke. Routine 
recommendations to initiate alcohol consumption to prevent cardiovascular disease 
should not be made in the absence of data from randomized controlled trials and the 
risk of abuse and addiction. However, in patients at risk for cardiovascular events 
who already responsibly consume alcohol, there is little reason to encourage 
abstinence.  
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Figure Legends 
 
Figure 1: Relationship between total mortality and alcohol intake extracted from 56 
curves using fixed- and random-effects models. (With permission from Di 
Castelnuovo, A et al. Arch Intern Med, 2006)[8] 
 
 
 
 
Figure 2: Alcohol consumption in relation to cardiovascular mortality in 
cardiovascular disease patients. (With permission from Costanzo, S et al. J Am Coll 
Cardiol, 2010)[9] 
 
 
 
 
Figure 3:  Beneficial mechanisms of light to moderate alcohol consumption 
 
 
 
 
Table 1: Studies showing beneficial effects of light to moderate alcohol consumption 
on cardiovascular or all-cause mortality 
 
 
Table 2: Studies showing neutral effects of light to moderate alcohol consumption on 
cardiovascular or all-cause mortality 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 1 
Study/Cohort 
 
Participants (n) 
 
Follow-up 
 
All-cause (or) CHD 
mortality 
 
Physicians’ Health 
Study[155] 
89,299 5.5 years Inverse association 
    
National Health Interview 
Survey[12] 
245,207 5 years Inverse association 
    
Framingham Heart 
Study[11] 
4,745 24 years U-shaped 
    
German Study[156] 2,084 8 years U-shaped 
    
British physicians[157] 
 
12,321 13 years U-shaped 
French Study[158] 34,014 10-15 years U-shaped 
 
Chinese men[159] 
 
18,244 
 
6.7 years 
 
U-shaped 
 
Cancer Prevention Study 
II [160] 
 
490,000 
 
9 years 
 
J-, U- or L-shaped 
    
Japanese Study[16] 
 
309,082 12.4 years J- or U-shaped 
Women’s Health 
Study[17] 
26,399 12.2 years J-shaped 
    
Women’s Health 
Initiative[19] 
116,186 8 years Inverse association 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 TABLE 2 
 
Study Cohort Participants 
(n) 
Follow-up All-cause (or) 
CHD 
mortality 
 
Comment 
NHEFS
[41]
 African-
American 
 
2,054 19 years No benefit None 
Hart et al.
[42]
 Scottish 5,766 21 years No benefit Increased 
mortality with 
> 22 drinks/wk 
 
INTERHEART
[43]
 Asian-
Indian 
4,465 N/A N/A No inverse 
effect on CHD, 
may be harmful 
 
Schooling et al.
[45]
 Chinese 54,090 4.2 years No benefit None 
 
Zhou et al.
[46]
 Chinese 1,476 N/A No benefit Moderate to 
heavy alcohol 
intake was 
detrimental for 
CHD 
 
Deev et al.
[47]
 Russian 4,153 13 years No benefit None 
 
Strandberg et 
al.
[48]
 
Finnish 1,808 29 years No benefit Heavy alcohol 
intake was 
detrimental 
 
Shaper et al.
[49]
 British 7,169 12.8 years No benefit >/= 3 drinks 
per day 
detrimental 
N/A – Not available 
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